Skip to content

Envoy Medical COCH Q1 2026 Annual earnings

Reported May 11, 2026 · Before market open

Revenue$39.0KMiss by $61.0K
EPS-$0.11Beat by $0.03
Revenue estimate$100.0K
EPS estimate-$0.14

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$100.0K
EPS estimate-$0.09

Financials

Q1 2026

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$51.04M+59.1%
P/S218.1×+73.6×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp

Returns & leverage

See full
Current ratio2.3×+1.2×

Versus estimates

Ask the moment Envoy Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Envoy Medical report Q1 2026 earnings?
Envoy Medical (COCH) reported Q1 2026 earnings on May 11, 2026 before market open.
What were Envoy Medical's Q1 2026 revenue and EPS?
Envoy Medical reported revenue of $39.0K and eps of $-0.11 for Q1 2026.
Did Envoy Medical beat estimates in Q1 2026?
Revenue missed the consensus estimate of $100.0K by $61.0K. EPS beat the consensus estimate of $-0.14 by $0.03.
How did Envoy Medical's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 15.2% from $46.0K a year earlier and eps grew 62.1% from $-0.29.
Where can I find Envoy Medical's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001213900-26-054185) and the 10-K/A periodic report (0001213900-26-043011) directly on SEC EDGAR. The filing index links above go to sec.gov.